The efficacy and safety of pre-hospital plasma in patients at risk for hemorrhagic shock: an updated systematic review and meta-analysis of randomized controlled trials
European Journal of Trauma and Emergency Surgery · 2024
DOI: 10.1007/s00068-024-02461-7 ↗Kurz gefasst
Metaanalyse in der Zeitschrift European Journal of Trauma and Emergency Surgery, 2024. Verfasst von Mohamed Abuelazm und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Tanta University, Tanta, Egypt. Hauptthemen laut MEDLINE: Blood Component Transfusion, Emergency Medical Services, Plasma, Shock, Hemorrhagic. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Al-Azhar University.
Abstract (Originalsprache)
Background and objective Plasma is a critical element in hemostatic resuscitation post-injury, and its prompt administration within the prehospital setting may reduce the complications resulting from hemorrhage and shock. Our objective is to assess the efficacy and safety of prehospital plasma infusion in patients susceptible to hemorrhagic shock.
Methods
We conducted our study by aggregating randomized controlled trials (RCTs) sourced from PubMed, EMBASE, Scopus, Web of Science, and Cochrane CENTRAL up to January 29, 2023. Quality assessment was implemented using the Cochrane RoB 2 tool. Our study protocol is registered in PROSPERO under ID: CRD42023397325.
Results
Three RCTs with 760 individuals were included. There was no difference between plasma infusion and standard care groups in 24-h mortality ( P = 0.11), 30-day mortality ( P = 0.12), and multiple organ failure incidences ( P = 0.20). Plasma infusion was significantly better in the total 24-h volume of PRBC units ( P = 0.03) and INR on arrival ( P = 0.009). For all other secondary outcomes evaluated (total 24-h volume of packed FFP units, total 24-h volume of platelets units, massive transfusion, vasopressor need during the first 24 h, any adverse event, acute lung injury, transfusion reaction, and sepsis), no significant differences were observed between the two groups.
Conclusion
Plasma infusion in trauma patients at risk of hemorrhagic shock does not significantly affect mortality or the incidence of multiple organ failure. However, it may lead to reduced packed red blood cell transfusions and increased INR at hospital arrival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, Tanta University, Tanta, Egypt.
- Faculty of Medicine, Al-Azhar University, Cairo, Egypt. HazemRezq.2020@azhar.edu.eg.
- Faculty of Medicine, Minia University, Minia, Egypt.
- Faculty of Medicine, Yarmouk University, Irbid, Jordan.
- Faculty of Medicine, Zagazig University, Zagazig, Egypt.
- Faculty of Medicine, The Hashemite University, Zarqa, Jordan.
Förderung
- Al-Azhar University
Zitieren
APA
Abuelazm, M., Rezq, H., Mahmoud, A., Tanashat, M., Salah, A., Saleh, O., Morsi, S., & Abdelazeem, B. (2024). The efficacy and safety of pre-hospital plasma in patients at risk for hemorrhagic shock: an updated systematic review and meta-analysis of randomized controlled trials. European Journal of Trauma and Emergency Surgery. https://doi.org/10.1007/s00068-024-02461-7
Vancouver
Abuelazm M, Rezq H, Mahmoud A, Tanashat M, Salah A, Saleh O, et al. The efficacy and safety of pre-hospital plasma in patients at risk for hemorrhagic shock: an updated systematic review and meta-analysis of randomized controlled trials. European Journal of Trauma and Emergency Surgery. 2024. doi:10.1007/s00068-024-02461-7
BibTeX
@article{Abuelazm2024,
author = {Abuelazm, Mohamed and Rezq, Hazem and Mahmoud, Abdelrahman and Tanashat, Mohammad and Salah, Abdelrahman and Saleh, Othman and Morsi, Samah and Abdelazeem, Basel},
title = {The efficacy and safety of pre-hospital plasma in patients at risk for hemorrhagic shock: an updated systematic review and meta-analysis of randomized controlled trials},
journal = {European Journal of Trauma and Emergency Surgery},
year = {2024},
doi = {10.1007/s00068-024-02461-7}
}
EUVIMED